Tina Normann, CMT, Featured In Financial Post With Cannabis Investment Comments

Tina Normann, CMT, of Eight Capital Equity Research, was featured in the Canadian Financial Post on Monday with comments on how several companies within the cannabis industry are faring relative to other healthcare companies. 

"[She] noted that the beta of cannabis stocks has recently spiked to around 2.0 from a range of 1.4 to 1.6, meaning they’re likely to post outsized moves in whatever direction the market is heading," said Bloomberg's Kristine Owram.

"As such, greater stability in the overall equity market, combined with sector-specific catalysts across the Canadian, U.S. and CBD markets, offer the potential for the cannabis sector to achieve outsized returns relative to other equities for the remainder of the calendar year," wrote Normann in a recent note.

Read the whole story here: Short sellers cash in on cannabis as investors get fed-up with money-losing companies.